We are delighted that our research was represented at the 2026 European Hematology Association (EHA) Congress in Stockholm, where Dr. Nargessadat Aghaallaei and Dr. Yüksel Filik Schüppler, postdoctoral researchers at our institute, presented their latest findings in cancer research and had the opportunity to discuss their work with international experts.